Good afternoon :)
Place Order
Add to Watchlist

Vimta Labs Ltd

VIMTALABS

Vimta Labs Ltd

VIMTALABS
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹1,032 cr, stock is ranked 1,276
High RiskStock is 4.45x as volatile as Nifty
448.753.61% (-16.80)
448.753.61% (-16.80)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹1,032 cr, stock is ranked 1,276
High RiskStock is 4.45x as volatile as Nifty

How to use scorecard? Learn more

Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹1,032 cr, stock is ranked 1,276
High RiskStock is 4.45x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
24.983.660.43%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
50.725.800.58%

Forecast & Ratings

Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Vimta Labs Limited is engaged in providing testing and contract research services in the fields of clinical and pre-clinical studies, clinical reference, analytical testing, advanced molecular biology and environmental studies.

Investor Presentation

View older 

Jul 28, 2023

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 11.74%, vs industry avg of 8.01%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 1.74% to 1.83%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 24%, vs industry avg of 15.02%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue117.57139.06154.79184.65214.57183.73211.51279.73321.63324.58
Raw Materialssubtract38.8427.3630.3929.5335.6432.4135.2554.8144.13233.85
Power & Fuel Costsubtract0.008.310.000.000.000.000.000.000.00
Employee Costsubtract28.8033.0543.1549.1055.1957.6357.8071.4286.32
Selling & Administrative Expensessubtract23.9630.7721.0723.2224.2926.5021.7328.5643.08
Operating & Other expensessubtract7.5119.6731.9236.3439.9834.2242.9444.4349.75
Depreciation/Amortizationsubtract11.1010.269.6315.7019.7220.9323.0823.3330.7134.15
Interest & Other Itemssubtract0.721.302.095.204.613.772.171.502.651.85
Taxes & Other Itemssubtract1.581.925.949.139.831.427.1414.3616.8313.41
EPS2.292.904.797.4311.453.109.6818.6921.7718.67
DPS1.001.000.002.002.000.002.002.002.002.00
Payout ratio0.440.340.000.270.170.000.210.110.090.11

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2023

Annual report

PDF

Investor Presentation

May 3PDF
FY 2024

Annual Report Pending

Investor Presentation

Jul 28PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareLabs & Life Sciences Services

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Vimta Labs Ltd21.433.660.43%
Divi's Laboratories Ltd51.057.290.86%
Syngene International Ltd58.857.550.18%
Aarti Pharmalabs Ltd20.772.580.45%

Price Comparison

Compare VIMTALABS with any stock or ETF
Compare VIMTALABS with any stock or ETF
VIMTALABS
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding36.98%1.49%0.00%2.88%58.66%

Mar 2023

Jun 2023

Sep 2023

Dec 2023

Shareholding History

SepDec '22MarJunSepDec '230.49%2.28%2.25%2.72%2.74%2.88%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 1 Mutual Funds holding Vimta Labs Ltd


Funds (Top 1)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Quant Small Cap Fund - Growth - Direct Plan

Growth
1.6259%0.10%-0.03%35/134 (0)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJun 21, 2023

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Jun 21, 2023

Cash Dividend

Ex DateEx DateJun 16, 2022

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Jun 16, 2022

Cash Dividend

Ex DateEx DateJun 25, 2021

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Jun 25, 2021

Cash Dividend

Ex DateEx DateJul 18, 2019

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Jul 18, 2019

Cash Dividend

Ex DateEx DateAug 14, 2018

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Aug 14, 2018